Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Afferi

Showing results (81-90 of 124) with videos related to

Pageof 13
Sort By:
European Urology Oncology|April 9, 2025
Oncological Outcomes in Bacillus Calmette-Guérin-naïve High-risk Non-muscle-invasive Bladder Cancer Patients: A Systematic Review on Current Treatment Strategies and Future PerspectivesMattia Longoni, Pietro Scilipoti, Francesco Soria, et al.
World Journal of Urology|May 26, 2025
Impact on oncological outcomes of detrusor muscle absence in pTaHG urothelial carcinoma of the bladder? The end of the "jump" of the lamina propria layer mythGabrielle Tissot, Pierre-Etienne Gabriel, Ulysse Dubuet, et al.
World Journal of Urology|July 27, 2020
Adjuvant chemotherapy is ineffective in patients with bladder cancer and variant histology treated with radical cystectomy with curative intentStefania Zamboni, Luca Afferi, Francesco Soria, et al.
Arab Journal of Urology|March 25, 2021
Comparing oncological outcomes of laparoscopic vs open radical nephroureterectomy for the treatment of upper tract urothelial carcinoma: A propensity score-matched analysisMarco Moschini, Stefania Zamboni, Luca Afferi, et al.
World Journal of Urology|May 2, 2020
The impact of treatment modality on survival in patients with clinical node-positive bladder cancer: results from a multicenter collaborationLuca Afferi, Stefania Zamboni, R Jeffrey Karnes, et al.
World Journal of Urology|February 10, 2022
Carboplatin-based adjuvant chemotherapy versus observation after radical cystectomy in patients with pN1-3 urothelial bladder cancerLuca Afferi, Chiara Lonati, Francesco Montorsi, et al.
European Urology Open Science|May 15, 2023
Carboplatin Induction Chemotherapy in Clinically Lymph Node-positive Bladder CancerMarkus von Deimling, Laura S Mertens, Bas W G van Rhijn, et al.
Targeted Oncology|November 13, 2024
Adjuvant Immune Checkpoint Inhibitors for Muscle-Invasive Urothelial Carcinoma: An Updated Systematic Review, Meta-analysis, and Network Meta-analysisTakafumi Yanagisawa, Keiichiro Mori, Akihiro Matsukawa, et al.
Minerva Urology and Nephrology|January 13, 2021
A comparison of perioperative outcomes of laparoscopic versus open nephroureterectomy for upper tract urothelial carcinoma: a propensity score matching analysisLuca Afferi, Mohammad Abufaraj, Francesco Soria, et al.
BJU International|July 9, 2025
Impact of timing of computed tomography staging and patient factors on the detection of 'true' cN+ bladder cancerMarkus von Deimling, Marc Furrer, Alberto Bianchi, et al.
Pageof 13

Showing results (81-90 of 124) with videos related to

Sort By:
Pageof 13
European Urology Oncology|April 9, 2025
Oncological Outcomes in Bacillus Calmette-Guérin-naïve High-risk Non-muscle-invasive Bladder Cancer Patients: A Systematic Review on Current Treatment Strategies and Future PerspectivesMattia Longoni, Pietro Scilipoti, Francesco Soria, et al.
World Journal of Urology|May 26, 2025
Impact on oncological outcomes of detrusor muscle absence in pTaHG urothelial carcinoma of the bladder? The end of the "jump" of the lamina propria layer mythGabrielle Tissot, Pierre-Etienne Gabriel, Ulysse Dubuet, et al.
World Journal of Urology|July 27, 2020
Adjuvant chemotherapy is ineffective in patients with bladder cancer and variant histology treated with radical cystectomy with curative intentStefania Zamboni, Luca Afferi, Francesco Soria, et al.
Arab Journal of Urology|March 25, 2021
Comparing oncological outcomes of laparoscopic vs open radical nephroureterectomy for the treatment of upper tract urothelial carcinoma: A propensity score-matched analysisMarco Moschini, Stefania Zamboni, Luca Afferi, et al.
World Journal of Urology|May 2, 2020
The impact of treatment modality on survival in patients with clinical node-positive bladder cancer: results from a multicenter collaborationLuca Afferi, Stefania Zamboni, R Jeffrey Karnes, et al.
World Journal of Urology|February 10, 2022
Carboplatin-based adjuvant chemotherapy versus observation after radical cystectomy in patients with pN1-3 urothelial bladder cancerLuca Afferi, Chiara Lonati, Francesco Montorsi, et al.
European Urology Open Science|May 15, 2023
Carboplatin Induction Chemotherapy in Clinically Lymph Node-positive Bladder CancerMarkus von Deimling, Laura S Mertens, Bas W G van Rhijn, et al.
Targeted Oncology|November 13, 2024
Adjuvant Immune Checkpoint Inhibitors for Muscle-Invasive Urothelial Carcinoma: An Updated Systematic Review, Meta-analysis, and Network Meta-analysisTakafumi Yanagisawa, Keiichiro Mori, Akihiro Matsukawa, et al.
Minerva Urology and Nephrology|January 13, 2021
A comparison of perioperative outcomes of laparoscopic versus open nephroureterectomy for upper tract urothelial carcinoma: a propensity score matching analysisLuca Afferi, Mohammad Abufaraj, Francesco Soria, et al.
BJU International|July 9, 2025
Impact of timing of computed tomography staging and patient factors on the detection of 'true' cN+ bladder cancerMarkus von Deimling, Marc Furrer, Alberto Bianchi, et al.
Pageof 13